Zobrazeno 1 - 10
of 36 028
pro vyhledávání: '"NATURAL KILLER CELLS"'
Publikováno v:
Experimental Hematology & Oncology, Vol 13, Iss 1, Pp 1-27 (2024)
Abstract Immunotherapy has transformed the landscape of cancer treatment, with chimeric antigen receptor (CAR)-engineered T (CAR-T) cell therapy emerging as a front runner in addressing some hematological malignancies. Despite its considerable effica
Externí odkaz:
https://doaj.org/article/4442d43ba4af488c81033163b80f83cb
Publikováno v:
Pharmaceutical Biology, Vol 62, Iss 1, Pp 367-393 (2024)
Context Rice bran arabinoxylan compound (RBAC) is a natural immunomodulator with anticancer properties.Objective This study critically evaluates the available evidence on the biological pathways of RBAC and its effects on cancer treatment.Methods Thi
Externí odkaz:
https://doaj.org/article/6c486ed29a3c4c3f8322eb0c6da4b1b5
Publikováno v:
International Journal of Nanomedicine, Vol Volume 19, Pp 12323-12342 (2024)
Jiale Wu,1,2 Kaihong Shi,1,2 Wei Chao,1,2 Zeyu Qin,1,2 Youhui Hu,1,2 Yihua Yang,1,2 Yuan He,1,2 Yabing Hua,1,2 Ziming Zhao1,2 1Department of Pharmacy, Xuzhou Medical University, Xuzhou, People’s Republic of China; 2Jiangsu Key Laboratory of New Dru
Externí odkaz:
https://doaj.org/article/b6abb4012b4d4a8cbfcf009ac0fe6a0f
Publikováno v:
口腔疾病防治, Vol 32, Iss 11, Pp 894-900 (2024)
Neutrophil extracellular traps (NETs) are fibrous web-like structures composed of decondensed chromatin and granular proteins released by neutrophils, with the ability to capture and kill bacteria. Pathogens, such as bacteria and viruses, can trigger
Externí odkaz:
https://doaj.org/article/2661ad5ee6e34b57beca1808b7fbf00f
Autor:
Kamlesh Bisht, Aimee Merino, Rob Igarashi, Laurent Gauthier, Marielle Chiron, Alexandre Desjonqueres, Eric Smith, Edward Briercheck, Rizwan Romee, Evren Alici, Eric Vivier, Michael O’Dwyer, Helgi van de Velde
Publikováno v:
Experimental Hematology & Oncology, Vol 13, Iss 1, Pp 1-18 (2024)
Abstract Despite therapeutic advancements, multiple myeloma (MM) remains incurable. NK cells have emerged as a promising option for the treatment of MM. NK cells are heterogenous and typically classified based on the relative expression of their surf
Externí odkaz:
https://doaj.org/article/0b35578717bf4584af3e0678d86f8cc2
Autor:
Farhana Jahan, Leena Penna, Annu Luostarinen, Laurens Veltman, Heidi Hongisto, Kaarina Lähteenmäki, Sabine Müller, Seppo Ylä-Herttuala, Matti Korhonen, Kim Vettenranta, Anita Laitinen, Urpu Salmenniemi, Erja Kerkelä
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-13 (2024)
Abstract Natural killer (NK) cells are a promising allogeneic immunotherapy option due to their natural ability to kill tumor cells, and due to their apparent safety. This study describes the development of a GMP-compliant manufacturing protocol for
Externí odkaz:
https://doaj.org/article/b4949fb2a86c4f2ea2ea182932cf3e7c
Autor:
Tirtha Mandal, Soorya Gnanasegaran, Golding Rodrigues, Shalini Kashipathi, Anurag Tiwari, Ashvini Kumar Dubey, Sanghamitra Bhattacharjee, Yogendra Manjunath, Subith Krishna, M. S. Madhusudhan, Maloy Ghosh
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-22 (2024)
Abstract Background High levels of LLT1 expression have been found in several cancers, where it interacts with CD161 on NK cells to facilitate tumor immune escape. Targeting LLT1 could potentially relieve this inhibitory signal and enhance anti-tumor
Externí odkaz:
https://doaj.org/article/2711c1481c15447aa9107618730b296c
Publikováno v:
Experimental Hematology & Oncology, Vol 13, Iss 1, Pp 1-26 (2024)
Abstract Cellular immunotherapy exploits the capacity of the human immune system in self-protection and surveillance to achieve the anti-tumor effects. Natural killer (NK) cells are lymphocytes of innate immune system and they display a unique inhere
Externí odkaz:
https://doaj.org/article/0f1d2215de564367a83425cc08cb63b4
Publikováno v:
ImmunoTargets and Therapy, Vol Volume 13, Pp 513-524 (2024)
Sumei Chen,1,* Lingrong Yang,2,* Bing Xia,3 Haitao Zhu,4 Zhenghao Piao,5 Youssef Jounaidi6 1Department of Radiation Oncology, Hangzhou Cancer Hospital, Hangzhou, Zhejiang, 310002, People’s Republic of China; 2Department of Hangzhou Cancer I
Externí odkaz:
https://doaj.org/article/35e0411b4a9549f1a4fdb3dd324e59ba
Publikováno v:
Breast Cancer: Targets and Therapy, Vol Volume 16, Pp 657-666 (2024)
Maria Vernet-Tomas,1,2 Ivonne Vazquez,1,3 Francesc Olivares,3 David Lopez,3 Jose Yelamos,2,4 Laura Comerma1– 3 1Breast Diseases Unit, Hospital Del Mar, Barcelona, Spain; 2Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM),
Externí odkaz:
https://doaj.org/article/d3514b3ec9dd4a878927add6d2df2734